Related Experiment Video
Updated: Apr 26, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Low treatment rates in patients meeting guideline criteria in diverse practice settings
Lily H Kim1, Vincent G Nguyen, Huy N Trinh
1Division of Gastroenterology and Hepatology, Stanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA, 94304, USA, lilyhkim@stanford.edu.
Insights
Treatment rates for chronic hepatitis B (CHB) vary by care setting. Hepatology clinics offer higher CHB treatment rates than primary care, underscoring the need for improved patient and provider education.
Area of Science:
- Hepatology
- Gastroenterology
- Primary Care Medicine
Background:
- Limited data exists on antiviral therapy usage and chronic hepatitis B (CHB) guideline adherence across diverse clinical settings.
- Evaluating treatment eligibility and initiation rates is crucial for optimizing CHB management.
Purpose of the Study:
- To assess the proportion of treatment-eligible CHB patients at 6-month follow-up.
- To determine the treatment rate among eligible CHB patients at 12-month follow-up in primary care, gastroenterology, and hepatology settings.
Main Methods:
- Retrospective cohort study of 1,976 treatment-naïve CHB patients.
- Patients categorized into primary care physician (PCP), gastroenterology (GI), and hepatology groups.
- Treatment eligibility assessed using US Panel 2008 and AASLD 2009 guidelines.
Main Results:
- Hepatology and GI groups showed similar eligibility rates (US Panel: 53-54%; AASLD: 24-25%).
- Treatment rates were significantly higher in hepatology vs. GI (US Panel: 59% vs. 45%).
- PCP group had the lowest eligibility and treatment rates; common non-treatment reasons included perceived normal ALT and patient preference.
Conclusions:
- Less than half of eligible CHB patients in primary care received treatment.
- Community GI and university liver clinics treated approximately 50-66% of eligible patients.
- Enhanced patient and provider education on CHB treatment benefits and updated ALT guidelines is recommended.
Background And Aims:
Data on usage of antiviral therapy and application of chronic hepatitis B (CHB) management guidelines in different settings are limited. Our goal is to evaluate the proportion of treatment-eligible patients by 6-month follow-up and treatment rate among eligible patients by 12-month follow-up in diverse settings.
Methods:
In this retrospective cohort study, 1,976 treatment-naïve CHB patients were categorized as primary care physician (PCP) group if seen by community PCP (n = 329), gastroenterology (GI) group if seen by community gastroenterologists (n = 1,268), and hepatology group if seen by university hepatologists (n = 379). Treatment eligibility was based on the US Panel 2008 and American Association for the Study of Liver Diseases (AASLD) 2009 guidelines.
Results:
All groups had similar age, gender, and ethnic distribution. GI and hepatology groups had similar treatment eligibility rates by US Panel (53-54 %) and AASLD guidelines (24-25 %). However, treatment rate was significantly higher in hepatology compared to GI group by the US Panel guideline (59 vs. 45 %, P = 0.001). PCP group had the lowest eligibility and treatment rates by both guidelines. Common reasons for non-treatment were perceived "normal" alanine aminotransferase, desire for further observation, and patient refusal. Male gender, age >50, and subspecialty care predicted treatment initiation in treatment-eligible patients.
Conclusions:
Less than half of treatment-eligible patients at primary care clinics received treatment. Community gastroenterology and university liver clinics treated about one-half to two-thirds of eligible patients. Patient and provider education should highlight treatment benefits and the new alanine aminotransferase upper limit of normal.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Dosage Regimen: Individualization
Regression Toward the Mean
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Bioequivalence of Drugs: Drugs with Multiple Indications